|
Quotes & Info
|
| GNVC > SEC Filings for GNVC > Form 8-K on 21-Nov-2008 | All Recent SEC Filings |
21-Nov-2008
Other Events, Financial Statements and Exhibits
On November 19, 2008, GenVec, Inc. issued a press release announcing interim survival data in its pivotal trial of TNFerade™ in locally advanced pancreatic cancer. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated in this report by reference.
(d) Exhibits
99.1 GenVec, Inc. press release dated November 19, 2008.
|
|